Ocular Therapeutix Inc (NASDAQ:OCUL)
| 4.91 Delayed Data As of Mar 23 |  +0.07 / +1.44%Today’s Change | 2.57 Today|||52-Week Range 6.53 | +74.73% Year-to-Date |
Latest OCUL News | Press Releases
No recent news for Ocular Therapeutix Inc.
Today’s Trading
| Previous close | 4.85 |
| Today’s open | 4.91 |
| Day’s range | 4.85 - 5.01 |
| Volume | 408,964 |
| Average volume (3 months) | 1,199,543 |
| Market cap | $403.8M |
Data as of 4:00pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -977.04% |
| Earnings growth (this year) | -10.25% |
| Earnings growth (next 5 years) | +43.00% |
| Revenue growth (last year) | +18.32% |
| P/E ratio | NM |
| Price/Sales | 4.20 |
| Price/Book | 11.37 |
Competitors
Data as of 4:00pm ET, 03/23/2023
Financials
| Next reporting date | May 12, 2023 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $51.5M |
| Annual profit (last year) | -$71.0M |
| Net profit margin | -137.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bedford, Massachusetts |
Forecasts
